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2ABSTRACT
Objective
This work aimed to evaluate the acceptability and validity of a Singapore-adapted GLF as
a tool for facilitation and evaluation of performance development in a group of general
level hospital pharmacists in a large tertiary Singapore hospital.
Methods
A prospective cohort study was conducted. Observational evaluations during daily
clinical activities were recorded for 35 pharmacists using the GLF at 2 time points over a
median of 9 months. Evaluations were followed by feedback; from which individualized
learning plans were formulated.
Results
Mean competency cluster scores improved for all 3 clusters and in all competencies. Of
63 behaviors, all but 8 showed significant improvement (p<0.05). Non-significant
improvements were due to the highest level of performance being attained upon initial
evaluation. The GLF process was a positive experience, prompting reflection on practice.
Conclusions
A Singapore-adapted GLF was an acceptable educational tool for the facilitation and
evaluation of performance development in general level hospital pharmacists.
Keywords: competency, pharmacist, General Level Framework, Singapore, hospital
pharmacy
3INTRODUCTION
Hospital pharmacists are essential members of the multidisciplinary team who promote
rational and cost-effective use of medicines, and improve patient outcomes by reducing
morbidity, mortality, adverse drug events and hospital length of stay.1-8 The role of
pharmacists using evidence-based practice to ensure patient safety and the best use of
medicines has been endorsed by the World Health Organization (WHO) and government
bodies at a global level.9-11 There is pressure on pharmacists to deliver these improved
patient outcomes in all developed and developing countries as the burden of disease
increases as a result of an aging population with multiple co-morbidities. To maximize
improved patient outcomes it is essential to have an adequate supply of appropriately
educated and clinically skilled pharmacists.
Singapore
The Singapore government has responded to this changing landscape by increasing
staffing levels of health care professionals by 40%, including funding extra pharmacists,
whose clinical role in Singapore is being increasingly recognized and developed.12,13 The
majority of hospital pharmacists in Singapore are currently relatively junior, with
approximately 65% having less than 3 years experience. It was identified that a regular
structured clinical mentoring and practitioner development system that included
standards for practice, self reflection, peer evaluation, feedback and directed learning
would be of additional benefit to the academic post-graduate opportunities already
available.
In a recent survey of the Australian Hospital Pharmacy workforce, a third of pharmacists
indicated that they would leave the department within 2 years if support for staff
development were not available.14 A structured, robust, evidence-based tool for
practitioner development could assist in ensuring a competent work force and act as a
primary motivator to increase job satisfaction and hence retention. Such a tool could also
identify common development areas for an entire cohort and direct training programs as
well as enabling departments to set and monitor service standards.
General Level Framework
While no single model may be appropriate for all cultures and contexts, there are
significant global health and labor market drivers that suggest a competency-based
approach is sensible and sustainable for workforce development.15-17 The Competency
and Education Development Group (CoDEG) in the UK used the Whiddett and
Holyforde model as a basis for developing a competency-based performance
development framework for general level pharmacists (those with less than 3 years post-
registration hospital experience).18-21 The general level framework (GLF) was developed
as a ward-based tool to facilitate the development and evaluation of pharmacists via
direct observation of their practice.22 This process was subsequently validated in general
level hospital pharmacists in the UK by Antoniou, et al, who demonstrated that
practitioners who received feedback on their performance and agreed a development plan
using the GLF up to 3 times in a 12 month period reached (and maintained) a defined
level of competence faster than those who were observed without this intervention.23
4Since then, similar frameworks have been developed globally, which have also
demonstrated contributions to achieving and measuring improvements in performance
over time in both hospital and community pharmacy settings.24- 29 In fact, such is the
current global interest in efficient programs for development and evaluation of
competencies for pharmacists, that the International Pharmaceutical Federation (FIP)
formed an ongoing partnership with WHO and United Nations Educational, Scientific
and Cultural Organization (UNESCO) in 2008 (Global Pharmacy Education Taskforce
www.fip.org/education ) which included an objective to develop a globally acceptable
competency framework.16,30,31
There are similarities between the role of a hospital pharmacist in Singapore when
compared to the UK and Australia. Therefore GLFs from the UK and Australia were
reviewed, and components from each adapted for use in a large tertiary Singapore
hospital by selecting and mapping relevant GLF competencies to the applicable
Singapore Pharmacy Council competencies.19,25,32 A working group of junior and senior
pharmacists who would be using the tool were consulted on the draft, a pilot was
conducted and revisions were made according to feedback. The final adapted GLF
consisted of 63 behavioral statements grouped within 14 competencies and distributed
into 3 competency clusters: Delivery of Patient Care, Problem Solving and Professional
(Tables 1-3). The performance level for each behavior related to frequency of their
demonstration: ‘rarely’, ‘sometimes’, ‘usually’ or ‘consistently’. The adapted GLF was
initially introduced at one large government hospital in June 2009, with a view to
extending this to the other SingHealth Institutions before being adopted island-wide.33
Objective
The aim of this prospective cohort study was to evaluate the acceptability and validity of
the adapted GLF as a tool for the facilitation and evaluation of performance development
for a group of general level pharmacists in a large tertiary hospital in Singapore.
METHODS
Training
The 8 GLF facilitators at the study site attended 2 in-house training afternoons
introducing the concepts of the GLF as a tool for performance development, evaluation
and feedback. Practical application was addressed further whereby 2 (super trainers) of
the 8 facilitators attended 2 half-day training seminars led by CoDEG and Medication
Services Queensland (MSQ) on principles of adult learning, effective feedback and
practical use of the GLF plus associated tools. Following this, each super trainer
conducted a self-evaluation using the GLF before observing a member of CoDEG or
MSQ complete a GLF evaluation and provide feedback to themselves and a peer. Super
trainers were subsequently responsible for providing training to others at their site of
practice. Each super trainer completed a feedback questionnaire.
All general level pharmacists at the study site attended an in-house training afternoon on
the principles of the GLF and associated professional development tools. Additional
5seminars on workplace education and work-based learning were provided by CoDEG and
MSQ, and attended by most GLF pharmacists at the study site. Feedback was sought
from the facilitators and general level pharmacists at regular intervals.
Study design
Thirty-five general level pharmacists working in the inpatient setting at one large tertiary
hospital in Singapore were enrolled into the study. GLF facilitators required general level
pharmacists in their clinical team to conduct a self-reflection on their current level of
performance using the GLF. This tool was subsequently used to conduct baseline and
repeat observational evaluations during daily clinical activities; followed by feedback,
from which individualized learning plans were formulated. All pharmacists underwent a
minimum of 2 evaluations over a median of 9 months. At each visit, the performance of
the individual for each behavior was rated from 1 to 4 (1=rarely; 2=sometimes;
3=usually; 4=consistently). If a behavior was not observed it was categorized as ‘not
assessed’. Baseline scores were calculated from the first evaluation in the study period
and repeat scores were calculated from the last.
Data collection and analysis
A password-protected database was created on Excel (2003) and the facilitators entered
results for each GLF evaluation.
For each behavior median scores and ranges were calculated, and the difference between
individual baseline and repeat observed performance was analyzed using the Wilcoxon
paired signed-rank test. Mean scores for competency clusters and competencies were
compared to illustrate the change in performance from baseline to repeat visit. Analysis
was carried out using the Statistical Package for Social Sciences (SPSS version 17).
Ethics approval was applied for and waived by the study site’s Institutional Review
Board.
RESULTS
Thirty-five general level pharmacists working in the inpatient setting at a large tertiary
hospital in Singapore underwent baseline and repeat observational evaluations between
June 2009 and December 2010.
All but one of the pharmacists enrolled in the study were female (97%). At baseline,
pharmacists had a median of 2 years post-registration experience (range 1 to 4). The
median time to repeat observation was 9 months (range 4 to 10), and pharmacists had a
total median of 3 observation visits (range 2 to 4).
An improvement in the mean competency cluster score was demonstrated for all 3
clusters (Fig 1) and in all competencies (Figs 2-4) from baseline to repeat evaluations.
6Of the 63 behaviors analysed, all but 8 showed significant improvement (p<0.05)
between baseline and repeat observations (Tables 1-3). In all cases, non-significant
improvements were the result of pharmacists being perceived to already be practicing at
the highest performance level upon the initial baseline evaluation. No decrease in
performance was demonstrated in any behavior.
The most significant improvements in performance were seen in the Problem Solving
cluster (Fig 3), where all behaviors demonstrated a significant improvement. Baseline
and repeat median scores were also generally lower in this cluster compared to the others
(Table 2). Problem Solving competencies included behaviors relating to: problem
identification, knowledge, analysis and recommendations and follow up.
Six of the behaviors that failed to demonstrate significant improvement were in the
Patient Care competency cluster; 5 of these related to the provision of medication
competency and one to the patient education competency (Table 1). All other Patient
Care competencies (patient consultation, gathering information, drug specific issues and
risk management and service improvement) showed a significant improvement.
The 2 other behaviors that failed to demonstrate significant improvement were in the
Professional cluster, relating to confidentiality and recognizing the value of team
members, which were categorized within the professionalism and teamwork
competencies (Table 3). The remaining 2 Professional competencies; organization and
communication skills, did show significant improvement.
Of the 21 year 1 and 2 general level pharmacists at the study site who underwent the first
round of evaluation with the GLF, 81% agreed that it ‘added value to their learning
experience’. Comments from the super trainers highlighted that the GLF process was an
overall positive experience that prompted refection on practice, although some found the
process to be taxing (Fig 5).
DISCUSSION
The adapted GLF was well received and proved a useful educational and development
tool that was able to demonstrate improvement in performance over time. The majority of
general level pharmacists to whom the tool was applied at the study site felt positively
about the contribution it made to their learning experience. Feedback from the super
trainers was very encouraging and indicated that the whole GLF process was well
received as a way to evaluate many different aspects of practice (attitudes, knowledge
and skills), provide inspiring and practical feedback on practice and prompt reflection
(Fig 5). The perceived negative aspects were few, though some felt uncomfortable being
observed and giving feedback to a peer and others found the process taxing, a sentiment
echoed by colleagues in the Queensland study.24 Both of these aspects are things that
become easier with time as the GLF becomes integrated into daily practice and as a more
open learning culture develops.
7Anecdotally, many pharmacists found the process of self-reflection almost as important
as the observed evaluation and feedback process. The process of self-reflection (which
forms a significant component of the GLF) is important to facilitate a greater
understanding of defined and accepted expectations and is consistent with adult learning
principles (self-reflection, feedback and needs-based learning).
Of the 63 behaviors analysed, all but 8 demonstrated a significant improvement between
baseline and repeat observations. In the 8 cases where no significant improvement was
observed, it was the result of pharmacists being perceived to already be practicing at the
highest performance level during the baseline evaluation. The competencies this applied
to related to tasks that were widely accepted to comprise fundamental roles of a hospital
pharmacist in Singapore, an observation that was reflected in other studies.23,24
Problem Solving competency cluster
The behaviors in the Problem Solving cluster all demonstrated a significant improvement,
and also the largest change in performance over time out of the 3 clusters (Table 2). This
reflects research findings from other countries using this tool and emphasizes the large
growth in problem solving skills that take place in the first years of practice.23,24 This
cluster measures more knowledge-based behaviors, such as describing the pharmacology
of drugs, pathophysiology of disease and mechanisms of interactions, which require a
more complex understanding and continual learning, compared to the process-based
behaviors that comprise the majority of the other 2 clusters. The process-based behaviors
that involve the learning and refining of processes related to daily activities appear to be
mastered faster, compared to knowledge-based behaviors, which are in effect subject to
continual improvement and can only be fully refined over time in conjunction with
appropriate mentoring and continued professional development.15
The lower median scores demonstrated in the Problem-Solving cluster, compared to the
other 2, suggest that this cluster may show the greatest improvement from continual
mentoring and guidance. It also highlights the gap between theory learned at university
and during the pre-registration year and application to practice. The UK has addressed
this with the introduction of a self-directed type Diploma in General Level Pharmacy
Practice, which incorporates the GLF to support the development of junior pharmacists,
using work-based learning and case-based assessments under the mentorship of a more
experienced practitioner.34 In response to the learning needs identified by the GLF, all
pharmacists at the study site were divided into clinical teams, with a senior pharmacist
designated to lead the team. The team met each week to discuss cases, share learning
experiences and to review GLF training needs.
Patient Care competency cluster
Eighteen of the 24 behaviors in the Patient Care cluster demonstrated significant
improvement in performance, including the behaviors around medication history taking
and allergy documentation (Table 1). When carried out by pharmacists, these activities
have been demonstrated to be more complete and result in reduced mortality.7,35-37 These
are therefore essential components of a clinical pharmacy service and it is important that
performance in these behaviors is maximized to improve patient outcomes.
8Six of the behaviors that failed to demonstrate significant improvement were in the
Patient Care competency cluster. Five of these related to the provision of medication, and
included ensuring that the: prescription was unambiguous and legal, medication label
contained the required information, correct drug, patient and label were provided and
medication supply was documented. These supply-related behaviors are traditionally seen
as some of the most well established roles of the pharmacist and were being performed at
the highest level at the baseline evaluation. Interestingly, ‘ensuring medication
availability’, 1 of the 5 behaviors within the provision of medication competency, did
show significant improvement, suggesting that this was perhaps not as obvious a role for
the general level pharmacist as the other 4 supply-related behaviors, and highlights how
the GLF can be a useful tool to set standards and ensure uniform provision of services.
A similar trend was seen in the behaviors relating to the patient education competency,
where provision of appropriate oral/written information did not show a significant
improvement over time due to the high level of baseline performance, but the advice on
non-pharmacotherapy treatments and assessing the patient’s understanding of the
information they had been given did show improvement. ‘Advice on non-drug therapy’
scored a median of 3 at both time points, and though as significant improvement was
demonstrated it was the lowest scoring behavior in the patient education competency.
This raises the question of whether it is necessary for pharmacists to be aiming for the top
performance level in all behaviors or if a department may wish to prioritize by setting
minimum standards of performance depending on staffing, expectations and targets.
Professional competency cluster
This cluster was the highest scoring of the 3 on repeat evaluation and contained the final
2 behaviors that failed to demonstrate significant improvement. These behaviors related
to confidentiality and recognizing the value of team members (Table 3). Again,
performance was already considered to be at the highest level upon the baseline
evaluation, suggesting that these values were instilled early in a pharmacist’s career. The
2 behaviors in this cluster that ranked the lowest at both time points were, ‘demonstrates
confidence’ and ‘active in educating and training healthcare professionals’. It is possible
that these 2 behaviors are linked, and pharmacists will become more involved in
education and training as they gain experience, and therefore confidence.
Benefits of the GLF
Clinical pharmacy services positively impact on patient care in many ways, including
reducing mortality.1-8 The GLF describes the behaviors and activities that this service
should comprise. Many competencies will be common requirements to all environments,
countries and cultures providing pharmaceutical care to patients, whilst others can be
adapted according to need and local requirements. Some behaviors describe good
practice, such as ‘opening the consultation’, whilst others set standards that reduce
morbidity, mortality and re-admission rates, for instance ‘allergy documentation’ and
‘medication reconciliation’.7,35 Other behaviors provide cost-effective care or reduce
potential unwanted effects, such as ‘ensures need for drug’ and ‘identify drug-drug
interactions’, respectively.1-6 Demonstrating significant improvements in performance
9not only drives improvements in patient care but also provides a framework for clinical
governance.
The GLF demonstrated improvements in performance over a median time of 9 months,
demonstrating that it is a valid tool for the measurement of performance over this
timeframe. There was also potential for further performance improvement after 9 months,
suggesting that this tool would be a valid development aid beyond this time period.
Impact of the GLF in Singapore
This is the first time the use of the GLF has been analysed in an Asian setting. The
introduction of this tool was received with generally positive feelings in a culture where
knowledge-based assessment is traditionally favoured over competency-based programs.
However, a shift in thinking is occurring and the value of individualized competency-
based development in addition to (not instead of) academic merit is being recognized by
many of the most influential clinical pharmacy leaders in Singapore, with the GLF now
adopted by a significant number of public healthcare institutions, with the others to
follow in the near future.
Initially pharmacists were nervous at the thought of having their practice observed, but
also quite excited at the prospect of having help from a more experienced mentor to
develop their practice. Pharmacists are traditionally used to working alone and it is rare to
have someone observe practice after the initial training period. Whilst hands on training
and observation are key components to the post-graduate development and training of
medical staff and other health care professionals in Singapore, clinical pharmacists have
largely been left to develop (and in many cases pioneer) their own practice. Some thrive
on this challenge, but many others require more support, empowerment and instruction.
Another argument in the support of observing professional practice is that all
practitioners should be open to having their practice reviewed by peers. Such interaction
provides the opportunity to ensure practitioners are providing safe and effective care to
patients and to congratulate when identified goals are achieved and tasks are performed
to agreed standards. This forms a pivitol role in clinical governance and the GLF can be
used as an effective tool by heads of pharmacy to measure how pharmacists are
performing against defined and accepted standards.
Comparison to other studies
The current study demonstrated significant improvements in 87% of all the behaviors
(n=63) evaluated over a median of 9 months. This compare to 95% (n=58; p<0.05) at 6
months (sustained at 12 months) in the original London study, and 57% (n=61; p<0.05)
over a median of 14 months in the Queensland study.23,24 Whilst performance
improvements are comparable between the London and Singapore cohorts, there is an
obvious disparity in relation to Queensland. The competency frameworks used in the 3
studies contained different behaviors and so a direct comparison is not feasible, however
some observations can be made.
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The weighting of behaviors in the London and Singapore frameworks were comparable,
whilst the Queensland framework had a larger focus on the Patient Care cluster (Table 4).
The Patient Care behaviors in the Queensland framework were very detailed and included
extra behaviors, such as: relevant patient background, patient’s understanding of illness
and patient’s experience of medication use. These behaviors generally had lower baseline
and repeat scores, perhaps indicating that other behaviors were prioritized over these.
The 8 behaviors that failed to show significant improvement in the Singapore study were
due to pharmacists already performing at the maximum level upon the initial evaluation.
This was true for 9 behaviors in the Queensland study (mainly relating to the Professional
cluster and the discharge facilitation competency), but the remaining 17 behaviors
(mainly in the Patient Care cluster) did not significantly improve, though most
demonstrated a trend towards improved performance. The explanation provided for this
was that these behaviors were associated with a deeper understanding of medication
related consultation. Indeed, if the Singapore GLF had been as detailed, perhaps a similar
trend would have been demonstrated.
Two of the behaviors that failed to demonstrate improved performance in the Queensland
study also included in this study’s GLF were, ‘medication reconciliation’ and
‘mechanisms of interactions’. It is interesting that these showed a significant
improvement in one country and not the other. The difference could be explained by
expectations and accepted standards of practice in the 2 countries. For example, the
Singapore GLF states that medication reconciliation should be done ‘when appropriate’,
whilst this is a standard procedure for all patients admitted to hospital in Queensland.
Maybe this disparity is due to time pressures, staffing levels, an understanding of the
importance of this process or the level of development of clinical pharmacy practice.
Only the study’s GLF contained a competency related to provision of medication, and
performance of most of the associated behaviors was maximal on initial evaluation. Now
that technicians have taken largely taken over the supply role in Singapore (as in London
and Queensland), perhaps these behaviors could be transferred to a technician level
framework.38,39
Limitations
The validity, sensitivity and reliability of the GLF evaluation process has previously been
evaluated.22,23 However, using such a tool is always open to individual assessor variation
in expectations. It was endeavored that the same facilitator should complete all
evaluations for an individual pharmacist throughout the study to reduce inter-rater
variability, however on some occasions this was not possible and 20% of pharmacists had
2 facilitators. The GLF can be used as a developmental tool for individual pharmacists,
independent of such variations, but the comparison of scores between individuals should
be done loosely, taking this limitation into account. In response to feedback from this
study, a handbook was produced as a reference for the trainers and trainees to provide
more detailed descriptions of the competencies to aid standardization of the process.33
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Feedback was obtained at regular intervals from the general level pharmacists, and 81%
of those surveyed indicated that the GLF added value to their leaning experience..
CONCLUSIONS
The GLF adapted for a large tertiary hospital in Singapore was an acceptable educational
tool for the facilitation and evaluation of performance development in general level
pharmacists. A single framework or target level of performance may not be appropriate
for all contexts, but the GLF is a useful development and evaluation tool that can be
tailored to local cultural needs and expectations of an institution.
Acknowledgments
Mr Lim Mun Moon, Head of Pharmacy, Singapore General Hospital.
Ms Angelina Tan, Principal Clinical Pharmacist, Singapore General Hospital.
Ms Jacquline Ong, Executive, Allied Health Division, Singapore General Hospital.
Prof J. Graham Davies, Professor of Clinical Pharmacy & Therapeutics, Kings College,
London.
Ms Jurate Svarcaite, research coordinator, CoDEG, UK.
REFERENCES
1. Boyko Jr.WL, Yurkowski PJ, Ivey MF, Armistead JA, Roberts BL. Pharmacist
influence on economic morbidity outcomes in a tertiary care teaching hospital. Am J
Health Syst Pharm. 1997;54(14):1591-1595.
2. McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA,
Tonn ME, Bailey TC. A prospective, randomized trial to assess the cost impact of
pharmacist-initiated interventions. Arch Intern Med. 1999;159:2306-2309.
3. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, pharmacist staffing, and
drug costs in United States hospitals. Pharmacotherapy. 1999;19(12):1354-1362.
4. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse
drug reactions in United States hospitals. Pharmacotherapy. 2006;26(6):735-747.
5. Bond CA, Raehl CL, Franke T. Interrelationships among mortality rates, drug costs,
total cost of care, and length of stay in United States hospitals: summary and
recommendations for clinical pharmacy services and staffing. Pharmacotherapy.
2001;21(2):129-141.
6. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds
and adverse events in the intensive care unit. JAMA. 1999;282:267-270.
7. Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing and hospital
mortality rates. Pharmacotherapy. 2007;27(4):481-493.
8. Borja-Lopetegi A, Webb D, Bates I, Sharott P. Association between clinical
medicines management services, pharmacy workforce and patient
outcomes. Pharmacy World & Science. 2008;30:418-19.
12
9. Developing Pharmacy Practice: A Focus on Patient Care [handbook]. Geneva: World
Health Organization and International Pharmaceutical Federation; 2006.
10. A Spoonful of Sugar: Medication Management in NHS Hospitals. Audit Commission
for Local Authorities and the National Health Service in England and Wales; 2001.
www.audit-Commission.gov.uk/SiteCollectionDocuments/AuditCommission
Reports/NationalStudies/nrspoonfulsugar.pdf. Accessed September 15, 2011.
11. Australian Pharmaceutical Advisory Council. Guiding principles to achieve
continuity in medication management. Canberra: Commonwealth department of
Health and Aging; 2005.
12. Singapore to increase its healthcare workforce by 40% over the next 5 years.
Healthlinks. 2008;2:1.
www.specialist.mohh.com.sg/downloads/Info_Corner_HeaLinks0208.pdf. Accessed.
June 12, 2011.
13. Yong Y I. Speech by Ms Young Ying-I, Permanent Secretary (Health) at the
inaugural educating pharmacists (Asia) 2010 symposium, 15 April 2010.
www.moh.gov.sg/mohcorp/speeches.aspx?id=24148. Accessed June 12, 2011.
14. Garrett T. Pharmacy workforce recruitment and retention: An Australian area health
service perspective. J Pharm Prac Res. 2008;38:183-7.
15. Burke JM, Miller WA, Spencer AP, et al. Clinical pharmacist competencies.
Pharmacotherapy. 2008;28:806-15.
16. Bruno A, Bates I, Brock T, Anderson C. Towards a global competency framework.
Am J Pharm Educ. 2010;74(1):Article 3.
17. Maitreemit P, Pongcharoensuk P, Kapol N, Armstrong E. Pharmacist perceptions of
new competency standards. Pharm Pract. 2008;6(3):113-120.
18. Whiddett S, Holyforde S. The competencies handbook. London: Institute of Personnel
and Development; 1999.
19. Competency Development and Education Group (CoDEG). GLF - General level
framework for pharmacist development in general pharmacy practice. 2nd Ed.
London; 2007.
www.codeg.org/fileadmin/codeg/pdf/GLF_October_2007_Edition.pdf. Accessed
June 12, 2011.
20. Davies GJ, Webb DG, McRobbie D, Bates I. A competency approach to fitness to for
practice. Pharm J. 2002;268:104-6.
21. McRobbie D, Webb DG, Bates I, Wright J, Davies JG. Assessment of clinical
competence: designing a competence grid for junior pharmacists. Pharm Educ.
2001;1:67-76.
22. Goldsmith GM, Bates IP, Davies JG, et al. A pilot study to evaluate clinical
competence in junior grade pharmacy practitioners. Pharm Educ. 2003;3:127-34.
23. Antoniou S, Webb DG, McRobbie D, et al. A controlled study of the general level
framework: results of the South of England competency study. Pharm Educ.
2005;5:201-7.
24. Coombes I, Avent M, Cardiff L, et al. Improvement in pharmacist’s performance
facilitated by an adapted competency-based general level framework. J. Pharm Prac
Res. 2010;40(2)111-118.
13
25. Queensland Health 2009. Queensland Health General Level Framework (GLF)
version 4. http://www.codeg.org/fileadmin/codeg/pdf/SMPU_GLF.pdf. Accessed
June 12, 2011.
26. Mills E, Farmer D, Bates I, Davies JG, Webb D, Mc Robbie D. Development of an
evidence led competency framework for primary care and community pharmacists.
Pharm J. 2005;275:48–52.
27. Mills E, Farmer D, Bates I, Davies G, Webb D. The General Level Framework: use in
primary care and community pharmacy to support professional development. Int
J Pharm Pract. 2008;16:325-331.
28. Meštrović A, Staničić Z, Bates I, et al. Evaluation of Croatian community
pharmacists’ patient care competencies using the General Level Framework. Am J
Pharm Educ. 2011;75(2):Article 36.
29. Meštrović A, Staničić Z, Hadžiabdić MO, et al. Tailored education and competency
development of Croatian community pharmacists using the General Level
Framework. Am J Pharm Educ. In press.
30. Anderson C, Bates I, Beck D, et al. The WHO UNESCO FIP Pharmacy Education
Taskforce: enabling concerted and collective global action. Am J Pharm Educ.
2008;72(6):Article 127.
31. Anderson C, Bates I, Futter B, Gal D, Rouse M, Whitmarsh S. Global perspectives of
pharmacy education and practice. World Medical & Health Policy. 2010;2(1):Article
2:5-18.
32. Singapore Pharmacy Council. Competency standards for Singapore pharmacists.
March 2010. http://www.spc.gov.sg/html/SPB_CompetencyStandards.html. Accessed
June 12, 2011.
33. SingHealth. General level framework handbook. 1st Ed. 2011.
www.codeg.org/fileadmin/codeg/pdf/singapore/SingHealth_GLF_Handbook_1st_Edi
tion_Feb2011.pdf. Accessed June 12, 2011.
34. JPB – Joint Programmes Board London East and South East of England. The
postgraduate diploma in general Pharmacy practice.
http://www.jpbsoutheast.org/diploma-programme/. Accessed September 30, 2011.
35. FitzGerald RJ. Medication errors: the importance of an accurate drug history. Br J
Clin Pharmacol. 2009;67:671–5.
36. Reeder TA, Mutnick A. Pharmacist-versus physician-obtained medication histories.
Am J Health Syst Pharm. 2008;65:857–60.
37. Carter MK, Allin DM, Scott LA, Grauer D. Pharmacist-acquired medication histories
in a university hospital emergency department. Am J Health Syst Pharm.
2006;63:2500–3.
38. Hough JE, Van Damme C, Obiolos Albinana L, Bates IP. Framework for pharmacy
technicians. Pharmacy Technician Journal. 2010;2:22.
39. Competency Development and Education Group (CoDEG). Framework for Pharmacy
Technicians (FPT). 1st Ed. London; 2010.
http://www.codeg.org/fileadmin/codeg/pdf/tlf/FPT_Grids_June_2010.pdf. Accessed
October 24, 2011.
Table 1. Evaluation of Behaviors in Patient Care Competency Cluster
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Baseline RepeatPatient Care Cluster
Competency/behaviors Number
Median
(range)
Number Median
(range) Exact Sig
Patient Consultation
- Opening consultation 35 4 (2-4) 34 4 (3-4) 0.002
- Questioning 34 3 (3-4) 34 4 (3-4) <0.001
Gathering information
- Allergies 35 4 (3-4) 35 4 (4) 0.025
- Relevant background 35 3 (2-4) 35 4 (3-4) <0.001
- Medication history taking 33 3 (2-4) 35 4 (3-4) <0.001
- Medication reconciliation 33 3 (1-4) 35 4 (2-4) <0.001
- Consultation on inconsistencies 33 4 (2-4) 35 4 (2-4) 0.002
Provision of Medication
- Prescription unambiguous 34 4 (3-4) 35 4 (4) 0.083a
- Prescription legal 35 4 (4) 35 4 (4) 1.000a
- Required information on label 35 4 (3-4) 34 4 (4) 0.157a
- Medicine availability 33 4 (2-4) 34 4 (2-4) 0.005
- Right drug, patient & label 33 4 (3-4) 33 4 (2-4) 0.083a
- Supply documented 33 4 (2-4) 33 4 (3-4) 0.059a
Drug Specific Issues
- Need for drug 35 3 (1-4) 35 4 (2-4) 0.001
- Cost-effectiveness 35 3 (1-4) 35 3 (2-4) <0.001
- Selection of formulation, concentration, rate &
diluent
34 3 (1-4) 33 4 (2-4) <0.001
- Administration of correct dose, frequency,
timing, route & duration
35 3 (3-4) 35 4 (3-4) <0.001
Patient Education
- Provision of oral/written information 34 4 (3-4) 33 4 (3-4) 0.102a
- Advice on non-drug therapy 34 3 (1-4) 33 3 (2-4) 0.008
- Assessment of patient’s comprehension 34 4 (2-4) 33 4 (3-4) 0.002
- Compliance assessment 34 3 (2-4) 32 4 (3-4) 0.001
- Need for information identified 34 3 (2-4) 33 4 (2-4) <0.001
- Documents medication errors 35 4 (2-4) 35 4 (3-4) 0.033
- Looks to improve quality of service 35 3 (1-4) 35 3 (2-4) <0.001
a Change in behavior non-significant at p=0.05 level
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Table 2. Evaluation of Behaviors in Problem Solving Competency Cluster
Baseline RepeatProblem Solving Cluster
Competency/behavior
Number Median
(range)
Number Median
(range) Exact Sig
Problem Identification
- Identify drug-drug interactions 34 3 (2-4) 35 4 (3-4) <0.001
- Identify drug-patient interactions 34 3 (1-4) 35 4 (2-4) <0.001
- Identify drug-disease interactions 35 3 (2-4) 35 3 (2-4) <0.001
- Problem prioritization 34 3 (1-4) 34 4 (2-4) <0.001
- Consults or refers appropriately 35 3 (1-4) 34 4 (3-4) 0.003
Knowledge
- Pathophysiology of disease 35 3 (1-4) 35 4 (2-4) <0.001
- Pharmacology 35 3 (2-4) 35 4 (2-4) <0.001
- Side-effects and monitoring 35 3 (2-4) 35 4 (3-4) 0.001
- Mechanism of interactions 35 3 (1-4) 35 3 (1-4) <0.001
Analysis and Recommendations
- Access guidelines/references 35 3 (2-4) 35 4 (2-4) 0.001
- Analyze information 34 3 (2-4) 34 3 (2-4) 0.002
- Identify evidence gaps 34 2 (1-3) 34 3 (1-4) 0.005
- Clear decision making 34 3 (1-4) 34 3 (1-4) 0.001
- Provide accurate information 35 3 (2-4) 33 4 (3-4) 0.001
- Provide relevant information 35 3 (2-4) 34 4 (3-4) <0.001
- Provide timely information 35 3 (2-4) 34 4 (3-4) <0.001
- Documentation of drug related problems 35 3 (2-4) 34 4 (3-4) 0.002
Follow Up
- Monitors drug therapy 35 3 (2-4) 35 4 (3-4) <0.001
- Ensures resolution of drug-related problems 35 3 (2-4) 35 4 (2-4) <0.001
Table 3. Evaluation of Behaviors in Professional Competency Cluster
Professional Cluster Baseline Repeat
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Table 4. Comparison of Performance Improvement
Number Median
(range)
Number Median
(range)
Organization
- Prioritizes work 35 3 (2-4) 35 4 (3-4) <0.001
- Punctual 35 3 (2-4) 35 4 (3-4) 0.003
- Uses time efficiently 35 3 (2-4) 35 4 (3-4) <0.001
- Demonstrates initiative 35 3 (2-4) 35 4 (2-4) 0.001
Professionalism
- Practice within Code of Ethics 35 4 (3-4) 35 4 (3-4) 0.046
- Maintains confidentiality 35 4 (3-4) 35 4 (3-4) 0.180b
- Demonstrates confidence 35 3 (2-4) 35 3 (2-4) 0.002
- Takes responsibility 35 4 (3-4) 35 4 (3-4) 0.020
- Describe structure and value of organization 34 3 (2-4) 35 4 (2-4) 0.007
- Uses up to date procedures 35 3 (2-4) 35 4 (2-4) 0.001
Communication Skills
- Appropriate communication with patient 35 4 (3-4) 35 4 (3-4) 0.002
- Appropriate communication with prescribers 35 4 (2-4) 35 4 (2-4) 0.002
- Appropriate communication with nursing staff 35 4 (3-4) 35 4 (3-4) 0.002
- Share learning, give feedback/guidance 34 3 (2-4) 34 4 (3-4) 0.007
- Education & training 34 2.5 (1-4) 34 3 (2-4) 0.001
Team Work
- Recognizes value of pharmacy team members 35 4 (3-4) 35 4 (3-4) 0.059b
- Works effectively as part of pharmacy team 35 4 (3-4) 35 4 (3-4) 0.004
- Passes on relevant information to pharmacy
team
35 4 (3-4) 35 4 (3-4) 0.008
- Recognizes value of multi-disciplinary team
members
35 4 (2-4) 35 4 (3-4) 0.070
- Works effectively as part of the multi-
disciplinary team
35 4 (2-4) 35 4 (2-4) 0.046
bChange in behavior non-significant at p=0.05 level
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Patient Care cluster Problem Solving cluster Professional cluster
Number of
behaviors
Significant
improvement
(%)
Number of
behaviors
Sig
improvement
(%)
Number of
behaviors
Sig
improvement
(%)
London 25 24 (96) 13 13 (100) 20 18 (90)
Queensland 43 25 (58) 9 6 (69) 9 5 (56)
Singapore 24 18 (75) 19c 19 (100) 20 18 (90)
c5 of these behaviors were included under the Patient Care cluster in the other 2 studies
Figure 1. Changes in Mean Individual Scores by Competency Clusters
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Figure 2. Changes in Mean Individual Scores for Patient Care Competencies
Figure 3. Changes in Mean Individual Scores for Problem Solving Competencies
Figure 4. Changes in Mean Individual Scores for Professional Competencies
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Figure 5. Feedback from Super Trainers Following GLF Evaluation (n=14)
